“It’s My Secret”: Shame as a Barrier to Care in Individuals With Opioid Use Disorder

Abstract

BACKGROUND:

Substance use disorder (SUD) is a chronic illness impacting more than 59 million Americans last year. Opioid use disorder (OUD) is a subset of SUD. The literature supports that healthcare providers frequently stigmatize patients with OUD. Individuals with OUD often feel shame associated with their disorder. Shame has been associated with maladaptive and avoidant behaviors.

AIM:

The aim of this qualitative descriptive study was to examine and describe the experiences of shame and health-seeking behaviors in individuals with OUD.

METHODS:

A qualitative exploratory design using focus groups with individuals in treatment for OUD was used to identify the issue of shame and its relationship to health-seeking behaviors.

RESULTS:

A systematic content analysis of discussions with 11 participants in four focus groups revealed four major themes and associated subthemes: Avoidance of Preventive Care (belief providers are judgmental); the Hidden Disorder (keeping secrets); Constraints of Shame (justification for the continuation of drug usage); and Trust in MOUD (Medication for Opioid Use Disorder) Providers. The feeling of shame leads to a reluctance to engage in health-promoting actions, such as scheduling appointments with primary care providers and dentists.

CONCLUSION:

Healthcare practitioners must prioritize providing a safe, nonstigmatizing environment for patients with SUD/OUD. This includes establishing trust and rapport, providing education, collaboration with psychiatric mental health specialists and other healthcare providers, and the offering support and resources to help patients manage their condition to achieve optimal health outcomes.

Keywords

opioid use disorder shame stigma primary care health promotion

Get full access to this article

View all access options for this article.

References

American Psychiatric Association. (2022a). Diagnostic and statistical manual of mental disorders: DSM-5-TR (5th ed., text rev.).

American Psychiatric Association. (2022b). Substance-related and addictive disorders. In Diagnostic and statistical manual of mental disorders (5th ed., text rev. pp. 543–553).

Bazemore

Petterson

Peterson

L. E.

Bruno

Chung

Phillips

R. L.

(2018). Higher primary care physician continuity is associated with lower costs and hospitalizations. The Annals of Family Medicine, 16(6), 492–497.

Binswanger

I. A.

Carroll

N. M.

Ahmedani

B. K.

Campbell

C. I.

Haller

I. V.

Hechter

R. C.

McNeely

Yarborough

B. J. H.

Kline-Simon

A. H.

Satre

D. D.

Weisner

Lapham

G. T.

(2019). The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Substance Abuse, 40(3), 292–301. https://doi.org/10.1080/08897077.2018.1545726

Birtel

M. D.

Wood

Kempa

N. J.

(2017). Stigma and social support in substance abuse: Implications for mental health and well-being. Psychiatry Research, 252, 1–8.

Centers for Disease Control and Prevention. (2023). The drug overdose epidemic: Behind the numbers. https://www.cdc.gov/opioids/data/index.html

Cha

A. E.

Cohen

R. A.

(2021). Urban-rural differences in dental care use among adults aged 18−64 (NCHS Data Brief, no 412). National Center for Health Statistics. https://doi.org/10.15620/cdc:106856externalicon

Cuberos

Chatah

E. M.

Baquerizo

H. Z.

Weinstein

(2020). Dental management of patients with substance use disorder. Clinical Dentistry Reviewed, 4(1), 14. https://doi.org/10.1007/s41894-020-00078-8

Etminan

Rezaeianzadeh

Kezouh

Aminzadeh

(2022). Association between sublingual buprenorphine-naloxone exposure and dental disease. Journal of the American Medical Association, 328(22), 2269–2271.

10.

Gao

Moran

Grimm

Toporek

Ruser

(2022). The effect of primary care visits on total patient care cost: Evidence from the Veterans Health Administration. Journal of Primary Care & Community Health, 13, 21501319221141792. https://doi.org/10.1177/21501319221141792

11.

Goodman

(2017). Contemporary trauma theory and trauma-informed care in substance use disorders: A conceptual model for integrating coping and resilience. Advances in Social Work, 18(1), 186–201. https://doi.org/10.18060/21312

12.

Hall

N. Y.

Majmudar

Mihalopoulos

(2021). Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence, 221, 108651. https://doi.org/10.1016/j.drugalcdep.2021.108651

13.

Hammarlund

Crapanzano

K. A.

Luce

Mulligan

Ward

K. M.

(2018). Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug-and alcohol-use disorders. Substance Abuse and Rehabilitation, 2018, 115–136. https://doi.org/10.2147/SAR.S183256

14.

Hartweg

D. L.

Metcalfe

S. A.

(2022). Orem’s Self-Care Deficit nursing theory: Relevance and need for refinement. Nursing Science Quarterly, 35(1), 70–76.

15.

Hawk

McCormack

Edelman

E. J.

Coupet

Toledo

Gauthier

Rotrosen

Chawarski

Martel

Owens

Pantalon

M. V.

O’Connor

Whiteside

L. K.

Cowan

Richardson

L. D.

Lyons

M. S.

Rothman

Marsch

Fiellin

D. A.

D’Onofrio

(2022). Perspectives about emergency department care encounters among adults with opioid use disorder. JAMA Network Open, 5(1), Article e2144955.

16.

Hudgins

Uzwiak

Pizzicato

Viner

(2021). Barriers to effective care: Specialty drug treatment in Philadelphia. Journal of Substance Abuse Treatment, 131, 108639. https://doi.org/10.1016/j.jsat.2021.108639

17.

Hunt

G. E.

Malhi

G. S.

Lai

H. M. X.

Cleary

(2020). Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: Systematic review and meta-analysis. Journal of Affective Disorders, 266, 288–304.

18.

Jones

C. M.

Noonan

R. K.

Compton

W. M.

(2020). Prevalence and correlates of ever having a substance use problem and substance use recovery status among adults in the United States, 2018. Drug and alcohol dependence, 214, 108169.

19.

Jones

A. C.

(2019). Stigma and shame: Conceptualisations and views concerning service use and health care provision: A literature review and commentary. Journal of Clinical and Medical Research, 2019(1). https://www.redelve.com/backend/images/article/1556952786.pdf

20.

Kane

S. F.

(2017). The effects of oral health on systemic health. Journal of General Dentistry, 65(6), 30–34.

21.

Kratovil

Schuler

M. S.

Vottero

B. A.

Aryal

(2023). Nurses’ self-assessed knowledge, attitudes, and educational needs regarding patients with substance use disorder. AJN: The American Journal of Nursing, 123(4), 26–33.

22.

Krueger

R. A.

(2014). Focus groups: A practical guide for applied research. Sage.

23.

Lazare

(1987). Shame and humiliation in the medical encounter. Archives of Internal Medicine, 147(9), 1653–1658.

24.

Levy

A. G.

Scherer

A. M.

Zikmund-Fisher

B. J.

Larkin

Barnes

G. D.

Fagerlin

(2018). Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians. JAMA Network Open, 1(7), Article e185293. http://europepmc.org/abstract/MED/30646397

25.

Lincoln

Guba

(1985). Naturalistic inquiry. Sage.

26.

Luoma

J. B.

Chwyl

Kaplan

(2019). Substance use and shame: A systematic and meta-analytic review. Clinical Psychology Review, 70, 1–12. https://doi.org/10.1016/j.cpr.2019.03.002

27.

McCurry

M. K.

Avery-Desmarais

Schuler

Tyo

Viveiros

Kauranen

(2023). Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare. Journal of Nursing Scholarship, 55(3), 701–710.

28.

McDonald

M. J. M. P. H

. (2020). Adverse childhood experience and substance use disorder: Exploring connections and trauma informed care. International Journal of Child Health and Human Development, 13(4), 383–387.

29.

Michas

(2022). U.S. population with emergency room visits 1997-2019, by age. https://www.statista.com/statistics/184432/us-population-with-emergency-room-visits-by-age/

30.

Moe

Camargo

Davis

Jelinski

S. E.

Rowe

B. H.

(2018). P135: Frequent emergency department use as an independent factor associated with mortality in substance and opioid misuse: A retrospective analysis of linked databases. Canadian Journal of Emergency Medicine, 20(Suppl. 1), S105.

31.

Muncan

Walters

S. M.

Ezell

Ompad

D. C.

(2020). “They look at us like junkies”: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal, 17, 1–9.

32.

National Center on Drug Abuse Statistics. (2021). Drug abuse statistics. https://drugabusestatistics.org/

33.

National Institute for Drug Abuse. (2021). Words matter—Terms to use and avoid when talking about addiction. https://nida.nih.gov/nidamed-medical-health-professionals/health-professions-education/words-matter-terms-to-use-avoid-when-talking-about-addiction

34.

Paris

Herriott

A. L.

Maru

Hacking

S. E.

Sommer

A. R.

(2020). Secrecy versus disclosure: Women with substance use disorders share experiences in help seeking during pregnancy. Maternal and Child Health Journal, 24(11), 1396–1403.

35.

Polit

Beck

(2021). Nursing research generating and assessing evidence for nursing practice (11th ed.). Wolters Kluwer.

36.

Santo

Kang

(2019). National Ambulatory Medical Care Survey: 2019 national summary tables. https://doi.org/10.15620/cdc:123251

37.

Simon

Snow

Wakeman

(2020). Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Substance Abuse, 41(4), 519–525.

38.

Sturman

Matheson

(2020). “I just hope they take it seriously”: Homeless men talk about their health care. Australian Health Review, 44(5), 748–754. https://doi.org/10.1071/AH19070

39.

Substance Abuse and Mental Health Services Administration. (2020). Treating drug use and prescription medication misuse in older adults. In Treating substance use disorder in older adults (Treatment Improvement Protocol [TIP] Series No. 26, SAMHSA Publication No. PEP20-02-01-011).

40.

Substance Abuse and Mental Health Services Administration. (2023). Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) practice guide. National Mental Health and Substance Use Policy Laboratory.

41.

Terrizzi

J. A.

Jr. Shook

N. J.

(2020). On the origin of shame: Does shame emerge from an evolved disease-avoidance architecture? Frontiers in Behavioral Neuroscience, 14, Article 19.

42.

Urbanoski

Pauly

Inglis

, et al, . (2020). Defining culturally safe primary care for people who use substances: A participatory concept mapping study. BMC Health Services Research, 20, Article 1060. https://doi.org/10.1186/s12913-020-05915-x

43.

Vasovic

Gajovic

Brajkovic

Jovanovic

Zdravkovaic

Kanjevac

(2016). The relationship between the immune system and oral manifestations of inflammatory bowel disease: A review. Central-European Journal of Immunology, 41(3), 302–310. https://doi.org/10.5114/ceji.2016.63131

44.

Ventura

C. A. A.

Carrara

B. S.

Fernandes

R. H. H.

Bobbili

S. J.

Eugênio

S. J.

de Ávila Domingos

S. G.

Ferreira

P. S.

(2022). General beliefs about illicit drug use and stigma: Perspective of people who use illicit drugs. Community Mental Health Journal, 58(7), 1346–1353. https://doi.org/10.1007/s10597-022-00944-8

45.

Wang

Q. Q.

Kaelber

D. C.

Volkow

N. D.

(2021). COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States. Molecular Psychiatry, 26(1), 30–39.

46.

L. T.

Zhu

Ghitza

U. E.

(2018). Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. Drug and Alcohol Dependence, 192, 316–323.

47.

Yang

L. H.

Wong

L. Y.

Grivel

M. M.

Hasin

D. S.

(2017). Stigma and substance use disorders: An international phenomenon. Current Opinion in Psychiatry, 30(5), 378–388. https://doi.org/10.1097/YCO.0000000000000351

48.

Zhang

Wang

Hou

Ali

Dora-Laskey

Dahlem

C. H.

McCabe

S. E.

(2021). Emergency department visits by patients with substance use disorder in the United States. Western Journal of Emergency Medicine, 22(5), 1076–1085.